National Pig Association - The voice of the British pig industry

PigWorld Logo

Home > News

News

23rd Mar 2017

Brussels

The Forum Awakens


We have had a flurry of posts on the forum since a rallying call from a poster to 'fire it up' earlier this week. 

22nd Mar 2017

Brussels

EU pigmeat exports continue to grow in 2017


Exports of fresh and frozen pork from Europe started 2017 strongly, following a good performance in 2016. 

22nd Mar 2017

Brussels

Lidl makes a commitment to British farming


Discount supermarket Lidl has signed a pledge confirming its commitment to British food and farming.

21st Mar 2017

NPANews

NPA chief executive updates FSA board on antibiotic progress


NPA chief executive Zoe Davies has updated the Food Standards Agency's (FSA) board on the progress the pig sector is making in reducing antibiotic usage.

21st Mar 2017

Brussels

Producer share of retail price reaches three-year high


The share of pork retail prices received by producers topped 40% in February, a three-year high, on the back of stable producer prices but falling retail prices.

20th Mar 2017

Brussels

NPA to work with EU colleagues on 'sensible' zinc oxide transition


The NPA will focus its attention persuading the European Commission to permit a 'sensible' transition period, after the CVMP reiterated its recommendation to ban zinc oxide. 

20th Mar 2017

Prices

UK slaughterings continue to be well down year-on-year


UK clean pig slaughterings continue to be well down year-on-year, supporting a stable price in the early months of 2017.

20th Mar 2017

NPANews

'Let's get the forum fired up!'


The forum has been quiet recently... 

18th Mar 2017

Prices

GB pigs short as SPP rises again - Peter Crichton commentary


Another firm day for sellers with the SPP moving up by 0.24p to stand at 150.18p and although German prices have stood on, GB pigs remain short. 

17th Mar 2017

Brussels

EU committee stands by zinc oxide ban recommendation


An EU veterinary committee has reasserted its view that zinc oxide should be banned at therapeutic levels, following a review of its evidence.

Campaigns